Potential Roles of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in Nondiabetic Populations

• Главные авторы: Dan Xu (Автор), Ankith Nair (Автор), Charlie Sigston (Автор), Chau Ho (Автор), Jia Li (Автор), Daya Yang (Автор), Xinxue Liao (Автор), Wei Chen (Автор), Ming Kuang (Автор), Yanbing Li (Автор), Christopher Reid (Автор), Haipeng Xiao (Автор)
• Формат: ‌
• Опубликовано: Hindawi-Wiley, 2022-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have been observed in several large cardiovascular outcome trials to significantly reduce the incidence of major cardiovascular event (MACE) with type 2 diabetic patients. The clinical trials of GLP-1 RAs, including lixisenatide, exenatide, lirag...